MedBlog

Brain

Saving Ryan: A dramatic tale of hope, persistence, and medical ingenuity

Diagnosed at age 3 with a rare genetic disorder, Ryan Dant was not expected to live beyond age 10. But thanks to his parents who never lost hope and a clinical trial at UT Southwestern, the now 29-year-old recently finished college and is looking forward to life’s next chapter. “It’s an incredible story,” says UTSW’s Elizabeth Maher, M.D., Ph.D., one of the specialists on his team.

Elizabeth Maher, M.D., Ph.D.

September 7, 2017

Cancer

Cancer clinical trials open for participants

These and other trials offer access to treatment options that would otherwise be unavailable to patients in the region – including a new investigation on acute myeloid leukemia.

June 15, 2017

Heart

Searching for answers: Why I’m studying obesity through clinical research

Clinical research allows physicians and scientists to discover new solutions to major health problems, such as obesity, heart disease, and diabetes.

Ian Neeland, M.D.

February 26, 2017

Cancer

Cancer Clinical Trials

Select cancer clinical trials that are open and seeking participants.

January 26, 2017

Cancer

No approved therapy? Consider becoming a research volunteer

Without research volunteers like Sheri Evans, clinical advancements toward new medical treatments simply aren’t possible.

Benjamin Greenberg, M.D.

December 1, 2016

Cancer

Game-changing lung cancer treatment may be at hand

Lung cancer can be difficult to treat. But a drug originally used to treat skin cancer is showing promise for improving quality of life for lung cancer patients like Donna Fernandez. Add your voice - #CallOutCancer today.

David Gerber, M.D.

December 2, 2015

Cancer

Cancer clinical trials offer hope...and more

Clinical trials are not just for advanced-stage cancer. UT Southwestern offers clinical trials for patients with newly diagnosed and recurrent cancers.

Thomas Froehlich, M.D.

July 15, 2015

Heart

New cholesterol-lowering drugs show promising results in trials

Clinical trials have shown promising results for a class of drugs that could dramatically lower cholesterol and, in turn, reduce the risk of heart disease.

Joseph A. Hill, M.D., Ph.D.

April 6, 2015